UCSF CME: 39th Annual Advances in Heart Disease 2022 (Videos)

Topics Explored at the 39th Annual Course

This esteemed course delves into the latest advancements in cardiovascular medicine, showcasing evidence-based findings that have transformed clinical practice in recent years.

Frontiers in Cardiology

• The Mind-Heart Connection: Unveiling the profound influence of stress and trauma on cardiovascular risk.
• Artificial Intelligence in Cardiology: Harnessing the power of AI to enhance diagnostics, optimize treatment decisions, and revolutionize patient care.
• Ascendant Thoracic Aortic Aneurysms: Exploring the complexities of evaluation, management, and genetic testing for these potentially life-threatening conditions.

State-of-the-Art Cardiovascular Interventions

• New Approaches to Pulmonary Embolism: Identifying cutting-edge techniques and strategies for managing this common and potentially fatal condition.
• Physiological Assessment of Coronary Stenosis Severity: Integrating CT Angiography and invasive catheterization data to refine diagnosis and guide treatment.
• Expanding Options in Endocarditis Management: Discussing novel approaches to combatting this serious infection of the heart valves.
• Surgical Approaches to Advanced Heart Failure: Exploring innovative surgical techniques for improving outcomes in patients with severe heart failure.
• Revascularization in Stable Coronary Disease: Balancing evidence and best practices to optimize treatment decisions.

Advances and Controversies in Electrophysiology

• Defining Sudden Cardiac Death in 2022: Redefining the criteria for identifying patients at highest risk of this life-threatening event.
• ECG Findings Suggesting High Arrhythmic Risk: Interpreting electrocardiographic patterns that indicate an elevated likelihood of developing arrhythmias.
• Debate: AFib Ablation Should be First Line Therapy: Evaluating the pros and cons of ablative procedures as the primary treatment approach for symptomatic atrial fibrillation.
• Advances in Cardiac Imaging for Arrhythmia Etiology, Prognosis, and Therapy: Leveraging advanced imaging modalities to improve diagnosis, predict outcomes, and guide treatment for arrhythmias.
• The Impact of Lifestyle and Alcohol on Atrial Fibrillation: Exploring the role of lifestyle factors, including exercise and alcohol consumption, in the development and management of atrial fibrillation.
• Interventions for Novel/Genetic Arrhythmias: Investigating targeted therapies for arrhythmias caused by genetic abnormalities.
• Debate: Prophylactic Primary Prevention ICD in Dilated Cardiomyopathy with Heart Failure: Weighing the evidence for and against prophylactic implantable cardioverter-defibrillators in patients with dilated cardiomyopathy and heart failure.

Managing Heart Failure

• Cardiogenic Shock: Understanding the pathophysiology, diagnosis, and management of this life-threatening condition.
• New Heart Failure Guidelines for HFrEF and HFpEF: Reviewing the latest clinical guidelines for managing heart failure with reduced ejection fraction (HFrEF) and heart failure with preserved ejection fraction (HFpEF).
• Polypharmacy and Medication Costs: Addressing the challenges and costs associated with guideline-directed medical therapy for HFrEF.
• Remote Monitoring of Cardiovascular Patients: Exploring the benefits and limitations of remote monitoring technologies for managing patients with cardiovascular diseases.

Managing Cardiovascular Risk

• The Effect of Salt and Salt Substitutes on Hypertension and Heart Failure: Investigating the impact of dietary salt intake on cardiovascular health.
• Managing Cardiovascular Risk in the Elderly: Tailoring cardiovascular risk management to the unique needs of elderly patients.
• Controversies and Agreements in Cholesterol Guidelines: Examining the latest cholesterol guidelines and addressing ongoing debates surrounding lipid management.
• Non-Statin Lipid Modifying Therapy: Exploring alternative therapeutic options for managing lipid disorders.
• Cardiovascular Risk and Chronic Kidney Disease in Diabetes: Assessing the interrelationship between cardiovascular risk, chronic kidney disease, and diabetes management.
• Impact of Air Pollution on Cardiovascular Outcomes: Understanding the health hazards associated with air pollution and its role in cardiovascular disease development.